CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $86,000 | -80.8% | 12,700 | -73.7% | 0.01% | -80.8% |
| Q2 2019 | $448,000 | +62.9% | 48,206 | +143.2% | 0.03% | +62.5% |
| Q1 2019 | $275,000 | +29.7% | 19,820 | +1.8% | 0.02% | +33.3% |
| Q4 2018 | $212,000 | -5.8% | 19,469 | +9.3% | 0.01% | +33.3% |
| Q3 2018 | $225,000 | +44.2% | 17,814 | -36.4% | 0.01% | +125.0% |
| Q3 2013 | $156,000 | -31.3% | 28,007 | +74.4% | 0.00% | -33.3% |
| Q2 2013 | $227,000 | – | 16,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |